(IBC3) iShares Core MSCI EM IMI - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00BD45KH83

Equities, Emerging Markets, Shares, Exposure

Description: IBC3 iShares Core MSCI EM IMI

The iShares Core MSCI EM IMI UCITS ETF (XETRA:IBC3) is an exchange-traded fund that tracks the Morningstar Emerging Markets TME NR USD Index, providing investors with broad exposure to emerging markets equities. As a Germany-domiciled ETF, it is designed to capture the performance of a diversified universe of large-, mid-, and small-cap stocks across various emerging markets.

From a technical analysis perspective, the ETFs price action indicates a relatively stable trend, with its 20-day simple moving average (SMA) at €4.50 and its 50-day SMA at €4.36, suggesting a potential bullish crossover. The 200-day SMA at €4.47 is closely aligned with the current price, indicating a strong support level. The average true range (ATR) of 0.05, equivalent to 1.22%, suggests moderate volatility. Given the current technical setup, we can anticipate a potential price movement towards the 52-week high of €4.75, with a possible resistance level around €4.60.

Fundamentally, the iShares Core MSCI EM IMI UCITS ETF has a substantial asset base, with approximately €19.952 billion in assets under management (AUM). This scale provides the ETF with a high degree of liquidity and diversification, making it an attractive option for investors seeking broad emerging markets exposure. As emerging markets continue to evolve, the ETFs diversified portfolio is well-positioned to capture growth opportunities across various sectors and geographies.

Combining technical and fundamental insights, our forecast suggests that the ETF is likely to experience a moderate price appreciation in the near term, driven by its strong technical setup and favorable fundamental characteristics. We anticipate the price to potentially reach €4.70 within the next few weeks, with a possible extension towards €4.80 in the event of a sustained bullish trend. However, investors should remain vigilant and monitor the ETFs price action and underlying fundamentals to adjust their strategies accordingly.

Additional Sources for IBC3 ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

IBC3 ETF Overview

Market Cap in USD 23,311m
Category Global Emerging Markets Equity
TER 0.18%
IPO / Inception 2018-03-05

IBC3 ETF Ratings

Growth Rating 33.1
Fundamental -
Dividend Rating 43.5
Rel. Strength -17.9
Analysts -
Fair Price Momentum 4.34 EUR
Fair Price DCF -

IBC3 Dividends

Dividend Yield 12m 2.49%
Yield on Cost 5y 3.35%
Annual Growth 5y 3.41%
Payout Consistency 95.1%
Payout Ratio %

IBC3 Growth Ratios

Growth Correlation 3m 86%
Growth Correlation 12m 31.9%
Growth Correlation 5y 38.2%
CAGR 5y 6.44%
CAGR/Max DD 5y 0.28
Sharpe Ratio 12m 0.95
Alpha -1.23
Beta 0.614
Volatility 12.85%
Current Volume 217.2k
Average Volume 20d 107.7k
Stop Loss 4.6 (-2.3%)
What is the price of IBC3 shares?
As of July 16, 2025, the stock is trading at EUR 4.71 with a total of 217,190 shares traded.
Over the past week, the price has changed by +1.57%, over one month by +2.68%, over three months by +13.57% and over the past year by +5.68%.
Is iShares Core MSCI EM IMI a good stock to buy?
Neither. Based on ValueRay´s Analyses, iShares Core MSCI EM IMI is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 33.10 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBC3 is around 4.34 EUR . This means that IBC3 is currently overvalued and has a potential downside of -7.86%.
Is IBC3 a buy, sell or hold?
iShares Core MSCI EM IMI has no consensus analysts rating.
What are the forecasts for IBC3 share price target?
According to our own proprietary Forecast Model, IBC3 iShares Core MSCI EM IMI will be worth about 4.9 in July 2026. The stock is currently trading at 4.71. This means that the stock has a potential upside of +3.61%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 4.9 3.6%